Stephen MacMahon AO's Publications

About Stephen MacMahon AO's Publications

Founding Director, The George Institute for Global Health
  • Professor of Cardiovascular Medicine, Faculty of Medicine, UNSW Sydney
  • Chair of Global Health, Faculty of Medicine, Imperial College of London
  • EGFR Exon 20 Insertion (A763_Y764insFQEA) Mutant NSCLC Is Not Identified by Roche Cobas Version 2 Tissue Testing but Has Durable Intracranial and Extracranial Response to Osimertinib

    Journal of Thoracic Oncology Date published:
  • Author response for "Obesity as a risk factor for <scp>COVID</scp> -19 mortality in women and men in the <scp>UK</scp> Biobank: comparisons with influenza/pneumonia and coronary heart disease"

    Unknown Date published:
  • Author response for "Obesity as a risk factor for <scp>COVID</scp> -19 mortality in women and men in the <scp>UK</scp> Biobank: comparisons with influenza/pneumonia and coronary heart disease"

    Unknown Date published:
  • Assessment of intestinal absorption/metabolism of 3-chloro-1,2-propanediol (3-MCPD) and three 3-MCPD monoesters by Caco-2 cells

    Toxicology in Vitro Date published:
  • Changing the Landscape: An Introduction to the Agricultural and Food Chemistry Technical Program at the 258th American Chemical Society National Meeting in San Diego

    Journal of Agricultural and Food Chemistry Date published:
  • Updated occurrence of 3-monochloropropane-1,2-diol esters (3-MCPD) and glycidyl esters in infant formulas purchased in the United States between 2017 and 2019

    Food Additives & Contaminants: Part A Date published:
  • Change in Blood Pressure Variability Among Treated Elderly Hypertensive Patients and Its Association With Mortality

    Journal of the American Heart Association Date published:
  • The impact of infant formula production on the concentrations of 3-MCPD and glycidyl esters

    Food Additives & Contaminants: Part A Date published:
  • Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)

    BMJ Open Date published:
  • SMARThealth India: A stepped-wedge, cluster randomised controlled trial of a community health worker managed mobile health intervention for people assessed at high cardiovascular disease risk in rural India

    PLOS ONE Date published:
  • Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

    The Lancet Date published:
  • Cardiovascular disease risk and comparison of different strategies for blood pressure management in rural India

    BMC Public Health Date published:
  • Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults

    European Heart Journal Date published:
  • Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies

    The Lancet Diabetes & Endocrinology Date published:
  • Estimated US infant exposures to 3-MCPD esters and glycidyl esters from consumption of infant formula

    Food Additives & Contaminants: Part A Date published:
  • Multimorbidity: a priority for global health research

    Date published: